Biotech Blog

Latest Articles

Biotechnology in Countries Starting with “I” – Part 13: Israel

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. In all candor, I had no long-term intentions in February 2013 when I started this irregular ...

Upcoming Talk: Finding and Evaluating BioPharmaceutical Market Entry Opportunities

I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities at the 13th Annual Pharma Resource Planning & Portfolio Management in Philadelphia, PA on February 6th, 2020. You can… The post Upcoming Talk: Finding and Evaluating Bio...

The effect of patent expiration on sales of branded competitor drugs in a therapeutic class

DrugPatentWatch was used in a recent research study on branded drug sales following generic entry. In this paper, authors Jeffrey Fujimoto, Daniel M Tien, Sophie Snyder, Jeppe A Hertz, and… The post The effect of patent expiration on sales of bran...

Customer Success: Will a generic version of a drug launch? And when?

DrugPatentWatch serves companies across the drug development-delivery sector. A common request among drug manufacturers, payers, and suppliers alike is anticipation of which branded drugs will face generic competition, and when… The post Customer ...

Customer Success: API and CDMO Business Development

Changes in drug markets can create growth opportunities for API manufacturers and CDMOs alike. Whether change comes from generic entry, from new formulations of drugs, or from competition from novel… The post Customer Success: API and CDMO Busines...